Bearnier AI vs building in-house AI for device regulatory research
At a glance
| Bearnier AI | In-house AI | |
|---|---|---|
| Time to first answer | Today | Months of engineering |
| FDA record ingestion | Done: summaries, De Novo, guidance, 21 CFR | Build scrapers; summaries are not bulk-downloadable |
| Scanned summaries | OCR’d and indexed | Your OCR pipeline to build and check |
| Freshness | Re-indexed weekly | Your job, every week |
| Citation accuracy | Published benchmark on 200 expert questions | Your evaluation to design and run |
| Your own documents | Private Team library | Fully under your control |
Facts about In-house AI from FDA 510(k) database and openFDA documentation, checked Oct 12, 2026.
Which to choose
Choose in-house AI if
- You have proprietary data that cannot leave your systems
- You already run an ML platform team
- You need deep integration with internal tools
Choose Bearnier AI if
- You want the FDA record answered now, not next year
- You would rather not maintain scrapers and OCR
- You want accuracy measured by someone accountable for it
Try the same question in both
Run it here and in in-house AI, then compare what each one can show you.
Questions about Bearnier AI and in-house AI
Why is the FDA record hard to build on?
FDA’s 510(k) database searches record fields such as product code and device name, not the summary text. Each summary is a separate PDF linked from its own page, many are scanned images, and predicate details are not in the bulk data.
Can I bring my own documents into Bearnier AI?
Soon. The Team plan is getting a private library for your submissions and FDA letters, visible only to your workspace and never used for training.